The document provides an overview of benchmark research on government affairs and public policy groups at leading biopharmaceutical companies. It finds that most participants held director-level or higher positions and that differentiated service levels are common. Nearly half of companies employ regional or hub-and-spoke models to balance centralized and local needs. Government affairs structures commonly follow business units, and intensive communication and goal setting are effective for collaboration.